We are pleased to announce that Jens Ellegaard and the Board of Directors of Ellegaard Göttingen Minipigs have decided to hand over the job as CEO to Mr. Lars Friis Mikkelsen as of February 1st 2015.
In close collaboration with Jens Ellegaard and the Board of Directors, Lars will develop Ellegaard further in the minipig business based on the company values, long standing relationships with our business partners and high quality minipigs, which Ellegaard's business is built on.
Lars holds a veterinary degree and a master degree in laboratory animal science from Copenhagen University as well as an Executive MBA from the National University of Singapore.
During his career, Lars worked in general veterinary practice, before he in 2000 joined the pharmaceutical industry, first by working at Novo Nordisk in Copenhagen and later at Merck/MSD in Singapore with responsibilities including both scientific and business areas.
At Novo Nordisk, Lars was globally responsible for external preclinical collaborations and lobbyism in relation to the use of research animals and at Merck/MSD in Singapore, he was Director of In Vivo Pharmacology and established and headed the In Vivo Pharmacology Section with special focus on non-human primate animal models within diabetes, obesity, dyslipidemia and CNS related therapeutic areas.
Jens Ellegaard will continue as part of the Ellegaard organization as Director of Strategy & Business Development and will concentrate on the strategic development of the company including the continued good collaboration with our business partners and strategic customers.